UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No.                )

 

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

  

Preliminary Proxy Statement

  

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

  

Definitive Proxy Statement

  

Definitive Additional Materials

  

Soliciting Material under §240.14a-12

KRYSTAL BIOTECH, INC.

 

(Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

   No fee required.

   Fee paid previously with preliminary materials.

   Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.


                                  
                        
   

 

Your Vote Counts!

          
 

 

KRYSTAL BIOTECH, INC.

 

2022 Annual Meeting

 

Vote by May 19, 2022

11:59 PM ET

        
   

 

KRYSTAL BIOTECH, INC.

2100 WHARTON ST, STE 701

PITTSBURGH, PA 15203

 

LOGO  

            

   
   
   
     
     

    

     
 
 
              
     

D65729-P66269

                                       
                                                    

You invested in KRYSTAL BIOTECH, INC. and it’s time to vote!

You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy material for the stockholder meeting to be held on May 20, 2022.

Get informed before you vote

View the Form 10-K and Notice and Proxy Statement online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 6, 2022. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy.

 

LOGO

 

 

*Please check the meeting materials for any special requirements for meeting attendance.

V1.1


Vote at www.ProxyVote.com

 

 

THIS IS NOT A VOTABLE BALLOT

This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters.

 

     Voting Items  

Board

Recommends

 

1.

 

Election of Class II Directors

Nominees:

  LOGO  For
  01)   Daniel S. Janney
  02)   Dino A. Rossi
    03)   E. Rand Sutherland
 

2.

  To ratify the appointment of Mayer Hoffman McCann P.C. as our independent registered public accounting firm for our fiscal year ending December 31, 2022.   LOGO  For
 

3.

  Approval of the compensation of the Company’s named executive officers, on a non-binding, advisory basis.   LOGO  For
 

4.

  Non-binding advisory approval of the frequency of the future stockholder advisory votes on the compensation of the Company’s named executive officers as being held every year, every two years, or every three years.   LOGO  Every       Year

NOTE: Such other business as may properly come before the meeting or any adjournment thereof.

      

 

 

Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”.

 

D65730-P66269

Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Krystal Biotech Charts.
Krystal Biotech (NASDAQ:KRYS)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Krystal Biotech Charts.